Literature DB >> 20141248

Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.

Lara A Ray1, Robert Miranda, Jennifer W Tidey, John E McGeary, James MacKillop, Chad J Gwaltney, Damaris J Rohsenow, Robert M Swift, Peter M Monti.   

Abstract

Polymorphisms of the mu-opioid receptor (OPRM1) and dopamine D4 receptor (DRD4) genes are associated with subjective responses to alcohol and urge to drink under laboratory conditions. This study examined these associations in the natural environment using ecological momentary assessment. Participants were non-treatment-seeking heavy drinkers (n = 112, 52% female, 61% alcohol dependent) who enrolled in a study of naltrexone effects on craving and drinking in the natural environment. Data were culled from 5 consecutive days of drinking reports prior to medication randomization. Analyses revealed that, after drinking, carriers of the Asp40 allele of the OPRM1 gene reported higher overall levels of vigor and lower levels negative mood, as compared to homozygotes for the Asn40 variant. Carriers of the long allele (i.e., >or=7 tandem repeats) of the DRD4 endorsed greater urge to drink than homozygotes for the short allele. Effects of OPRM1 and DRD4 variable-number-of-tandem-repeats genotypes appear to be alcohol dose-dependent. Specifically, carriers of the DRD4-L allele reported slight decreases in urge to drink at higher levels of estimated blood alcohol concentration (eBAC), and Asp40 carriers reported decreases in vigor and increases in negative mood as eBAC rose, as compared to carriers of the major allele for each gene. Self-reported vigor and urge to drink were positively associated with alcohol consumption within the same drinking episode. This study extends findings on subjective intoxication, urge to drink, and their genetic bases from controlled laboratory to naturalistic settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20141248      PMCID: PMC3703617          DOI: 10.1037/a0017550

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  59 in total

1.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

Review 2.  Review of neurotransmitters and their role in alcoholism treatment.

Authors:  C K Erickson
Journal:  Alcohol Alcohol       Date:  1996-03       Impact factor: 2.826

Review 3.  Strategies for analyzing ecological momentary assessment data.

Authors:  J E Schwartz; A A Stone
Journal:  Health Psychol       Date:  1998-01       Impact factor: 4.267

4.  DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations.

Authors:  B Freeman; J Powell; D Ball; L Hill; I Craig; R Plomin
Journal:  Behav Genet       Date:  1997-05       Impact factor: 2.805

5.  Simple non-invasive method to obtain DNA for gene analysis.

Authors:  N Lench; P Stanier; R Williamson
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

6.  Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.

Authors:  A C King; J R Volpicelli; A Frazer; C P O'Brien
Journal:  Psychopharmacology (Berl)       Date:  1997-01       Impact factor: 4.530

7.  Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Arch Gen Psychiatry       Date:  2007-09

8.  Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.

Authors:  Kent E Hutchison; Angela Wooden; Robert M Swift; Andrew Smolen; John McGeary; Lawrence Adler; Lyndee Paris
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

9.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.

Authors:  Francesca M Filbey; Lara Ray; Andrew Smolen; Eric D Claus; Amy Audette; Kent E Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

View more
  69 in total

1.  Affective response to physical activity as an intermediate phenotype.

Authors:  Harold H Lee; Jessica A Emerson; Lauren Connell Bohlen; David M Williams
Journal:  Soc Sci Med       Date:  2018-11-10       Impact factor: 4.634

2.  Evaluating a cognitive model of ALDH2 and drinking behavior.

Authors:  Christian S Hendershot; Katie Witkiewitz; William H George; Tamara L Wall; Jacqueline M Otto; Tiebing Liang; Mary E Larimer
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

3.  Responses to alcohol and cigarette use during ecologically assessed drinking episodes.

Authors:  Thomas M Piasecki; Phillip K Wood; Saul Shiffman; Kenneth J Sher; Andrew C Heath
Journal:  Psychopharmacology (Berl)       Date:  2012-04-27       Impact factor: 4.530

4.  Appetitive startle modulation in the human laboratory predicts Cannabis craving in the natural environment.

Authors:  Ethan H Mereish; Hayley Treloar Padovano; Stephanie Wemm; Robert Miranda
Journal:  Psychopharmacology (Berl)       Date:  2018-04-05       Impact factor: 4.530

5.  The interaction between the dopamine receptor D4 (DRD4) variable number tandem repeat polymorphism and perceived peer drinking norms in adolescent alcohol use and misuse.

Authors:  Aesoon Park; Jueun Kim; Michelle J Zaso; Stephen J Glatt; Kenneth J Sher; Lori A J Scott-Sheldon; Tanya L Eckert; Peter A Vanable; Kate B Carey; Craig K Ewart; Michael P Carey
Journal:  Dev Psychopathol       Date:  2016-02-23

Review 6.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

Review 7.  Assessment of Alcohol Use in the Natural Environment.

Authors:  Thomas M Piasecki
Journal:  Alcohol Clin Exp Res       Date:  2019-03-01       Impact factor: 3.455

8.  Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

Authors:  Robert Miranda; Hayley Treloar Padovano; Joshua C Gray; Stephanie E Wemm; Alexander Blanchard
Journal:  Addict Behav       Date:  2018-01-10       Impact factor: 3.913

9.  An event-level examination of sex differences and subjective intoxication in alcohol-related aggression.

Authors:  Patrick D Quinn; Cynthia A Stappenbeck; Kim Fromme
Journal:  Exp Clin Psychopharmacol       Date:  2013-02-18       Impact factor: 3.157

10.  Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity.

Authors:  Lara A Ray; Spencer Bujarski; James MacKillop; Kelly E Courtney; Peter M Monti; Karen Miotto
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.